ID27503A - Tts yang mengandung antioksidan - Google Patents

Tts yang mengandung antioksidan

Info

Publication number
ID27503A
ID27503A IDW20001301A ID20001301A ID27503A ID 27503 A ID27503 A ID 27503A ID W20001301 A IDW20001301 A ID W20001301A ID 20001301 A ID20001301 A ID 20001301A ID 27503 A ID27503 A ID 27503A
Authority
ID
Indonesia
Prior art keywords
antioxide
tts
ethyl
carbamate
oxidant
Prior art date
Application number
IDW20001301A
Other languages
English (en)
Indonesian (id)
Inventor
Bodo Asmussen
Michael Horstmann
Kai Kopke
Harry Tiemessen
Original Assignee
Novartis Ag Cs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10825116&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID27503(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag Cs filed Critical Novartis Ag Cs
Publication of ID27503A publication Critical patent/ID27503A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Dental Preparations (AREA)
IDW20001301A 1998-01-12 1999-01-08 Tts yang mengandung antioksidan ID27503A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9800526.7A GB9800526D0 (en) 1998-01-12 1998-01-12 Organic compounds

Publications (1)

Publication Number Publication Date
ID27503A true ID27503A (id) 2001-04-12

Family

ID=10825116

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001301A ID27503A (id) 1998-01-12 1999-01-08 Tts yang mengandung antioksidan

Country Status (25)

Country Link
US (1) US6335031B1 (cs)
EP (1) EP1047409B1 (cs)
KR (1) KR100569051B1 (cs)
CN (1) CN1129427C (cs)
AT (1) ATE223711T1 (cs)
AU (1) AU745661B2 (cs)
BR (1) BR9906920A (cs)
CA (1) CA2315784C (cs)
CZ (1) CZ300598B6 (cs)
DE (1) DE69902875T2 (cs)
DK (1) DK1047409T3 (cs)
ES (1) ES2184408T3 (cs)
GB (1) GB9800526D0 (cs)
HU (1) HU227159B1 (cs)
ID (1) ID27503A (cs)
IL (1) IL137100A (cs)
MX (1) MXPA00006438A (cs)
NO (1) NO328390B1 (cs)
NZ (1) NZ505650A (cs)
PL (1) PL201328B1 (cs)
PT (1) PT1047409E (cs)
RU (1) RU2219926C2 (cs)
SK (1) SK284622B6 (cs)
TR (2) TR200001688T2 (cs)
WO (1) WO1999034782A1 (cs)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE286725T1 (de) * 1998-10-01 2005-01-15 Novartis Pharma Gmbh Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe
FR2793689B1 (fr) * 1999-05-19 2001-08-24 Pf Medicament Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
AU779523B2 (en) * 1999-11-29 2005-01-27 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic systems with improved stability and a method for the production thereof
DE10107663B4 (de) * 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
ITMI20020798A1 (it) * 2002-04-15 2003-10-15 F T Holding S A Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici
FR2881653A1 (fr) * 2005-02-04 2006-08-11 Frederic Khodja Dispositif permettant l'administration en continu d'une dose physiologique controlee d'au moins un mineral ou une vitamine
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
WO2009022345A1 (en) * 2007-08-14 2009-02-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Phenyl carbamates for the treatment of multiple sclerosis
GEP20146122B (en) * 2008-07-28 2014-07-25 Takeda Pharmaceuticals Co Pharmaceutical composition
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
AU2010335309B2 (en) 2009-12-22 2015-08-20 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
ES2363395B1 (es) * 2010-01-20 2012-02-23 Farmalider, S.A. Composición farmacéutica l�?quida de rivastigmina o de una de sus sales de adición de �?cido para la administración por v�?a oral.
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
KR101892764B1 (ko) * 2010-07-21 2018-08-28 쓰리엠 이노베이티브 프로퍼티즈 컴파니 경피 접착제 조성물, 디바이스, 및 방법
DK2468274T3 (en) * 2010-12-14 2015-08-31 Acino Ag Transdermal therapeutic system for administration of an active substance
KR101788802B1 (ko) * 2010-12-24 2017-10-20 주식회사 삼양바이오팜 리바스티그민을 함유하는 경피흡수제제
KR20120126898A (ko) * 2011-05-13 2012-11-21 에스케이케미칼주식회사 리바스티그민 또는 이의 염을 함유하는 경피 투여 조성물
BR112013029945A2 (pt) 2011-05-20 2017-01-31 Sk Chemicals Co Ltd emplastro contendo rivastigmina
KR20120130073A (ko) * 2011-05-20 2012-11-28 에스케이케미칼주식회사 리바스티그민 함유 패취
EP2594261A1 (en) 2011-11-18 2013-05-22 Labtec GmbH Composition for transdermal administration of rivastigmine
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
WO2013142339A1 (en) 2012-03-23 2013-09-26 Novartis Ag Transdermal therapeutic system and method
WO2013187451A1 (ja) 2012-06-12 2013-12-19 株式会社 ケイ・エム トランスダーム 貼付剤
WO2014034939A1 (ja) * 2012-09-03 2014-03-06 ニプロパッチ株式会社 貼付剤
KR20140038237A (ko) * 2012-09-20 2014-03-28 에스케이케미칼주식회사 리바스티그민의 안정성이 개선된 의약품
WO2014051128A1 (ja) 2012-09-28 2014-04-03 株式会社 ケイ・エム トランスダーム 貼付剤
WO2014111790A2 (en) 2013-01-15 2014-07-24 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
EP3129012A4 (en) * 2014-04-08 2017-10-11 Teikoku Pharma USA, Inc. Rivastigmine transdermal compositions and methods of using the same
WO2015174502A1 (ja) 2014-05-15 2015-11-19 ニチバン株式会社 リバスチグミンを含有する貼付剤のための包装体
KR102823139B1 (ko) 2018-08-31 2025-06-19 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
KR102710072B1 (ko) 2018-08-31 2024-09-24 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
CN115087445A (zh) * 2020-02-19 2022-09-20 住友制药株式会社 经皮吸收制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL195004C (nl) * 1987-03-04 2003-11-04 Novartis Ag Fenylcarbamaat bevattend farmaceutisch preparaat.
GB9213322D0 (en) * 1992-06-23 1992-08-05 Efamol Holdings Antioxidant compositions
WO1998030243A1 (en) * 1997-01-08 1998-07-16 Warner-Lambert Company Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease
WO1998031356A1 (en) * 1997-01-17 1998-07-23 Takeda Chemical Industries, Ltd. Idebenone containing combination agent for treating alzheimer's disease

Also Published As

Publication number Publication date
MXPA00006438A (es) 2003-07-21
PL201328B1 (pl) 2009-03-31
BR9906920A (pt) 2000-10-10
CN1129427C (zh) 2003-12-03
HUP0004300A2 (hu) 2001-05-28
KR100569051B1 (ko) 2006-04-10
ATE223711T1 (de) 2002-09-15
JP2002500178A (ja) 2002-01-08
IL137100A (en) 2004-12-15
HK1034036A1 (en) 2001-10-12
PT1047409E (pt) 2002-12-31
IL137100A0 (en) 2001-06-14
DK1047409T3 (da) 2002-12-30
EP1047409A1 (en) 2000-11-02
NZ505650A (en) 2002-10-25
US6335031B1 (en) 2002-01-01
SK284622B6 (sk) 2005-08-04
PL341347A1 (en) 2001-04-09
CA2315784A1 (en) 1999-07-15
CA2315784C (en) 2006-06-27
NO20003472L (no) 2000-08-07
EP1047409B1 (en) 2002-09-11
AU2278599A (en) 1999-07-26
AU745661B2 (en) 2002-03-28
KR20010033072A (ko) 2001-04-25
SK10532000A3 (sk) 2000-11-07
HUP0004300A3 (en) 2003-05-28
CZ20002557A3 (cs) 2000-10-11
JP3820103B2 (ja) 2006-09-13
NO20003472D0 (no) 2000-07-05
HU227159B1 (en) 2010-09-28
DE69902875D1 (de) 2002-10-17
CN1288375A (zh) 2001-03-21
NO328390B1 (no) 2010-02-08
GB9800526D0 (en) 1998-03-11
DE69902875T2 (de) 2003-05-22
CZ300598B6 (cs) 2009-06-24
WO1999034782A1 (en) 1999-07-15
RU2219926C2 (ru) 2003-12-27
TR200001688T2 (tr) 2000-11-21
TR200101021T2 (tr) 2002-06-21
ES2184408T3 (es) 2003-04-01

Similar Documents

Publication Publication Date Title
ID27503A (id) Tts yang mengandung antioksidan
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
BR0107869A (pt) Composições farmacêuticas eletrogiradas
AR037081A1 (es) Composicion para el suministro transdermico de fentanilo
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
ATE383849T1 (de) Transdermale pharmazeutische zusammensetzung
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
TR200100812T2 (tr) Akut ağrı tedavisi için fentanil kompozisyon.
TR199802108T2 (xx) �bandronat i�eren oral farmas�tik bir form�lasyon.
BR0109150A (pt) Método para administração de um anestésico local a um indivìduo em necessidade de um efeito anestésico local, emplastro, composição, e, recipiente
ES2167116T3 (es) Sistema terapeutico transdermico (tts) que contiene pergolida.
CY1108700T1 (el) Συνθεσεις απελευθερωσης φαρμακου εστερα αλφα-υδροξυ οξεος και μεθοδοι χρησης
ATE493973T1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
DE60019334D1 (de) Antivirale arznei
DK1303278T3 (da) Kombination af et transdermalt terapeutisk system og et oralt og/eller parenteralt præparat indeholdende dopaminagonister til behandling af dopaminerge sygdomme
DK1300143T3 (da) Plaster som indeholder 4-biphenyleddikesyre
HRP20080178T3 (hr) Farmaceutski pripravak u obliku hidrogela za transdermalnu primjenu aktivnih tvari
IL155273A0 (en) Pharmaceutical compositions comprising an aplidine compound
PT1144420E (pt) Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao
IT1291895B1 (it) Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
HRP20070441T3 (hr) Farmaceutska kombinacija za liječenje grčeva i/ili boli
AU8900498A (en) Compounds and pharmaceutical compositions thereof for eliciting analgesic effects